I. Filar, M. Witkowski, W. Ryżewska, and T. Robak, “Recombinant ADAMT S-13 as a new alternative for the patients with congenital thrombocytopenic purpura”, OncoReview, vol. 14, no. 3(55), pp. 59-63, Dec. 2024.